Drugs / Tartrazine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06800183 | May → Dec 2026 | — | Johns Hopkins University | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tartrazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06800183 ↗ |
| Known as | FD\&C Yellow No. 5 | “Tartrazine, also known as FD\&C Yellow No. 5” NCT06800183 ↗ |
| Route | Topical | “topical application of tartrazine” NCT06800183 ↗ |